Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea · Delayed Price · Currency is KRW 4,380.00
+10.00 (0.23%)
At close: Aug 24, 2026
Sinsin Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4,373 | 3,876 | 539.85 | 346.46 | 2,240 | 799.33 |
Cash & Short-Term Investments | 4,373 | 3,876 | 539.85 | 346.46 | 2,240 | 799.33 |
Cash Growth | 356.19% | 618.05% | 55.82% | -84.53% | 180.24% | -68.08% |
Accounts Receivable | 34,312 | 32,808 | 30,605 | 27,975 | 25,771 | 23,237 |
Other Receivables | 2,190 | 2,061 | 2,229 | 2,216 | 1,953 | 1,652 |
Receivables | 36,502 | 34,869 | 32,833 | 30,191 | 27,724 | 24,889 |
Inventory | 21,268 | 19,976 | 16,643 | 15,733 | 14,390 | 10,370 |
Prepaid Expenses | 137.2 | 140.27 | 103.01 | 160.45 | 34.91 | 33.79 |
Other Current Assets | 952.96 | 558.51 | 1,374 | 676.95 | 659.08 | 375.07 |
Total Current Assets | 63,234 | 59,420 | 51,492 | 47,108 | 45,048 | 36,467 |
Property, Plant & Equipment | 63,399 | 64,020 | 65,718 | 68,264 | 66,825 | 69,345 |
Long-Term Investments | 8,729 | 7,652 | 6,649 | 3,270 | 3,559 | 3,183 |
Other Intangible Assets | 559.09 | 563.38 | 580.53 | 586.32 | 592.29 | 499.07 |
Long-Term Accounts Receivable | -0 | 0 | -0 | -0 | -0 | -0 |
Long-Term Deferred Tax Assets | 1,687 | 1,846 | 1,666 | 1,612 | 1,400 | 1,394 |
Other Long-Term Assets | 3,873 | 3,996 | 3,379 | 3,570 | 3,790 | 3,418 |
Total Assets | 141,482 | 137,497 | 129,484 | 124,409 | 121,213 | 114,307 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 7,898 | 5,791 | 7,256 | 7,060 | 6,815 | 4,746 |
Accrued Expenses | 1,397 | 1,424 | 902.13 | 845.07 | 864.38 | 784.18 |
Short-Term Debt | 38,406 | 20,374 | 20,706 | 16,142 | 11,794 | 12,720 |
Current Portion of Long-Term Debt | 1,476 | 21,930 | 20,793 | 18,384 | 12,629 | 8,590 |
Current Portion of Leases | 88.52 | 127.34 | 170.47 | 76.79 | 132.21 | 116.44 |
Current Income Taxes Payable | 891.73 | 801.32 | 273.84 | 169.82 | 186.45 | - |
Other Current Liabilities | 12,172 | 9,916 | 8,999 | 9,042 | 9,907 | 6,962 |
Total Current Liabilities | 62,330 | 60,363 | 59,101 | 51,720 | 42,327 | 33,919 |
Long-Term Debt | 840 | 1,209 | 3,822 | 9,843 | 18,865 | 24,676 |
Long-Term Leases | 35.27 | 55.28 | 115.36 | 59.01 | 61.44 | 133.54 |
Pension & Post-Retirement Benefits | - | - | - | - | 115.17 | 198.36 |
Other Long-Term Liabilities | 1,376 | 1,350 | 877.82 | 696.83 | 313.31 | 580.1 |
Total Liabilities | 64,581 | 62,977 | 63,915 | 62,319 | 61,682 | 59,507 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 7,585 | 7,585 | 7,585 | 7,585 | 7,585 | 7,585 |
Additional Paid-In Capital | 10,506 | 14,450 | 14,450 | 14,450 | 14,450 | 14,450 |
Retained Earnings | 58,836 | 53,236 | 44,875 | 41,019 | 37,478 | 32,890 |
Comprehensive Income & Other | 295.88 | -442.37 | -1,037 | -759.18 | 184.15 | 1.31 |
Total Common Equity | 77,223 | 74,829 | 65,874 | 62,295 | 59,698 | 54,927 |
Minority Interest | -323.13 | -308.99 | -304.86 | -204.62 | -166.81 | -126.43 |
Shareholders' Equity | 76,900 | 74,520 | 65,569 | 62,090 | 59,531 | 54,800 |
Total Liabilities & Equity | 141,482 | 137,497 | 129,484 | 124,409 | 121,213 | 114,307 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 40,846 | 43,695 | 45,606 | 44,505 | 43,481 | 46,236 |
Net Cash (Debt) | -36,473 | -39,818 | -45,066 | -44,158 | -41,241 | -45,437 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2406.42 | -2624.72 | -2968.47 | -2910.81 | -2718.51 | -2995.06 |
Filing Date Shares Outstanding | 15.17 | 15.17 | 15.17 | 15.17 | 15.17 | 15.17 |
Total Common Shares Outstanding | 15.17 | 15.17 | 15.17 | 15.17 | 15.17 | 15.17 |
Working Capital | 904.27 | -942.28 | -7,608 | -4,612 | 2,720 | 2,548 |
Book Value Per Share | 5090.37 | 4932.54 | 4342.22 | 4106.33 | 3935.14 | 3620.62 |
Tangible Book Value | 76,664 | 74,266 | 65,293 | 61,709 | 59,106 | 54,428 |
Tangible Book Value Per Share | 5053.51 | 4895.40 | 4303.95 | 4067.68 | 3896.09 | 3587.73 |
Land | 13,944 | 13,944 | 13,944 | 13,944 | 13,860 | 13,722 |
Buildings | 44,709 | 44,666 | 44,477 | 44,264 | 44,093 | 43,922 |
Machinery | 35,586 | 34,812 | 33,875 | 32,628 | 27,545 | 26,864 |
Construction In Progress | - | 375.5 | - | - | - | - |